Company—Capital Expenditures—Pilot Plant” for additional discussion of our Pilot Plant. Net cash used in investing activities of A$20,640,000 for the six months ended December 31, 2021 increased A$8,333,000 compared to the six months ended December 31, 2020 and was driven primarily by an increase in detail and vendor engineering activity.
Financing Activities
Net cash provided by financing activities of A$76,378,000 in 2021 increased A$37,702,000 compared to 2020 and was driven by an A$80 million placement of ordinary shares in ioneer Limited. Net cash provided by financing activities of A$38,326,000 in 2020 increased A$38,113,000 compared to 2019 and was driven by a A$40 million placement of ordinary shares in ioneer Limited. Net cash provided by financing activities of A$92,795,000 for the six months ended December 31, 2021 increased A$92,808,000 compared to the six months ended December 31, 2020 and was driven by a US$70 million (A$96 million) placement of ordinary shares by Sibanye Stillwater Limited in ioneer Limited.
| Liquidity and Capital Resources |
In fiscal 2021, 2020 and 2019, we incurred a loss of A$0.941 million, A$5.446 million and A$10.326 million, respectively, and had accumulated losses of A$43.407 million as of June 30, 2021. For the six month periods ended December 31, 2021 and 2020, respectively, we incurred a loss of A$6.495 million and A$5.764 million, respectively, and had accumulated losses of A$49.902 million as of December 31, 2021. We have not yet commenced commercial production at any of our properties and expect to continue to incur losses during the exploration, evaluation, and development of the Project.
Our operations have been financed primarily by proceeds from issuances of ordinary shares. Our cash and cash equivalent position at June 30, 2021 was A$83.078 million, compared to A$38.268 million as at June 30, 2020, compared to A$48.604 million as at June 30, 2019. Our cash and cash equivalent position at December 31, 2021 was A$148.964 million.
Subsequent to the end of fiscal 2021, we announced a proposed placement of 145.9 million shares at an issue price of A$0.6553 per share to Sibanye-Stillwater. Proceeds from the placement will be used to fund working capital, the costs necessary to advance the Project to commencement of construction and long-lead items and other capital costs. The placement was approved by shareholders at an Extraordinary General Meeting held on October 21, 2021 and we subsequently issued 145.9 million ordinary shares to Sibanye-Stillwater.
Capital Expenditures and Requirements
Our capital expenditures for fiscal 2021, 2020, and 2019 amounted to A$27.8 million, A$44.4 million and A$33.6 million, respectively. Our capital expenditures for each of the six month periods ended December 31, 2021 and 2020 amounted to A$20.6 million and A$12.3 million, respectively. Our capital expenditures for fiscal 2021, 2020, and 2019, and for each of the six month periods ended December 31, 2021 and 2020, related primarily to the Definitive Feasibility Study, the Pilot Plant, permitting expenditures, land option and water rights payments, ongoing detail engineering and vendor engineering. See “Item 4. Information on the Company—Capital Expenditures—Pilot Plant” for additional discussion of our Pilot Plant.
We estimate that development of the Project will require approximately US$785 million. If we ultimately make an FID to develop the Project, we will need to secure substantial additional funds to complete development. We expect to obtain a US$490 million equity contribution from Sibanye-Stillwater as part of the Strategic Partnership, subject to the satisfaction of conditions precedent. One condition is that debt financing for the Project will be secured. Even if the conditions precedent are met and Sibanye-Stillwater makes a US$490 million equity contribution, we may need to secure substantial additional funds, through future debt or equity financings, to complete development of the Project.
We also may decide to pursue additional debt or equity financing activities to facilitate further exploration, evaluation and development activities.
If we decide to raise capital by issuing equity securities, the issuance of additional ordinary shares or ADSs would result in dilution to our existing shareholders. We cannot assure you that we will be successful in completing any financings or that any such debt or equity financing will be available to us if and when required or on satisfactory terms.